Amsterdam, Netherlands

Stewart Thomas Cole

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Stichting Vumc. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stewart Thomas Cole. Retrieved from https://idiyas.com/inventor/stewart-thomas-cole

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stewart Thomas Cole: Innovator in Mycobacterial Research

Introduction

Stewart Thomas Cole is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical research, particularly in the area of mycobacterial infections. His innovative work has led to the development of a patent that addresses critical health challenges.

Latest Patents

Cole holds a patent for the "Inhibition of mycobacterial type VII secretion." This invention relates to compounds and pharmaceutically acceptable salts thereof, along with their medical applications. The exemplary medical uses include the prevention and treatment of bacterial infections, specifically mycobacterial infections that can affect the respiratory system and other areas. The patent also covers the use of these compounds as chemotherapeutic agents, highlighting their potential in inhibiting mycobacterial type VII secretion.

Career Highlights

Throughout his career, Stewart Thomas Cole has worked with prominent institutions such as Stichting VUmc and Stichting Amsterdam UMC. His research has focused on developing innovative solutions to combat bacterial infections, showcasing his commitment to advancing medical science.

Collaborations

Cole has collaborated with notable colleagues, including Eelco Ruijter and Mark Karsten Rong. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Stewart Thomas Cole's contributions to the field of mycobacterial research exemplify the impact of innovation in medicine. His patent for inhibiting mycobacterial type VII secretion represents a significant advancement in the treatment of bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…